Oppenheimer Analyst Ratings & Stock Recommendations (NYSE:OPY)

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Oppenheimer. These ratings and price targets were collected from pubilc media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Oppenheimer.

DateBrokerageActionCompany
Name
RatingPrice
Target
Impact on
Share Price
Actions
1/18/2019OppenheimerRaises TargetAtlassian (TEAM)$95.00 -> $110.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/18/2019OppenheimerUpgradesFiserv (FISV)Market Perform -> Outperform$74.50 -> $88.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/17/2019OppenheimerRaises TargetGoldman Sachs Group (GS)Outperform$257.00 -> $272.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/17/2019OppenheimerLowers TargetSix Flags Entertainment (SIX)$80.00 -> $68.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/16/2019OppenheimerUpgradesCarlisle Companies (CSL)Buy $125.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/16/2019OppenheimerSet Price TargetVaccinex (VCNX)Buy $22.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/16/2019OppenheimerRaises TargetUnitedHealth Group (UNH)Outperform$300.00 -> $305.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/16/2019OppenheimerRaises TargetMirati Therapeutics (MRTX)Outperform$57.00 -> $65.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/16/2019OppenheimerInitiatesVBI Vaccines (VBIV)Outperform$9.00 -> $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/15/2019OppenheimerUpgradesEncore Capital Group (ECPG)Market Perform -> Outperform $37.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/11/2019OppenheimerSet Price TargetEnPro Industries (NPO)Buy $90.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/13/2019OppenheimerSet Price TargetSpero Therapeutics (SPRO)Buy $30.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/14/2019OppenheimerSet Price TargetPortola Pharmaceuticals (PTLA)Buy $30.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/14/2019OppenheimerReiteratesValeritas (VLRX)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
1/14/2019OppenheimerRaises TargetCatabasis Pharmaceuticals (CATB)Outperform$7.00 -> $77.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/10/2019OppenheimerSet Price TargetITT (ITT)Buy $68.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/11/2019OppenheimerReiteratesbluebird bio (BLUE)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
1/11/2019OppenheimerSet Price TargetIovance Biotherapeutics (IOVA)Buy $25.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/11/2019OppenheimerSet Price TargetForty Seven (FTSV)Buy $35.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/11/2019OppenheimerLowers TargetJefferies Financial Group (JEF)$32.00 -> $30.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/11/2019OppenheimerLowers TargetAcuity Brands (AYI)$170.00 -> $166.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/10/2019OppenheimerDowngradesDollar Tree (DLTR)Outperform -> Market Perform$92.00 -> $104.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/9/2019OppenheimerReiteratesNVIDIA (NVDA)Outperform $250.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/9/2019OppenheimerLowers TargetSEI Investments (SEIC)Outperform$68.00 -> $60.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/9/2019OppenheimerUpgradesWendys (WEN)Market Perform -> Outperform $20.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/8/2019OppenheimerSet Price TargetBioMarin Pharmaceutical (BMRN)Hold $92.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/8/2019OppenheimerInitiatesCarGurus (CARG)Buy $42.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/8/2019OppenheimerDowngradesRegal Beloit (RBC)Outperform -> Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
1/8/2019OppenheimerLowers TargetVMware (VMW)Outperform$180.00 -> $170.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/8/2019OppenheimerUpgradesNordson (NDSN)Market Perform -> Outperform $140.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/8/2019OppenheimerInitiatesMagnolia Oil & Gas (MGY)Outperform $15.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/8/2019OppenheimerUpgradesLittelfuse (LFUS)Market Perform -> Outperform $215.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/8/2019OppenheimerReiteratesHubbell (HUBB)Outperform -> Market PerformMediumView Rating Details  Share on Twitter  Share on StockTwits
1/8/2019OppenheimerReiteratesHoneywell International (HON)Outperform -> Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
1/7/2019OppenheimerDowngradesSkyworks Solutions (SWKS)Outperform -> Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
1/7/2019OppenheimerLowers TargetFortinet (FTNT)$97.00 -> $88.00LowView Rating Details  Share on Twitter  Share on StockTwits
1/7/2019OppenheimerReiteratesSkyworks Solutions (SWKS)Outperform -> Market Perform $110.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/4/2019OppenheimerSet Price TargetEpizyme (EPZM)Buy $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/6/2019OppenheimerSet Price TargetNeurocrine Biosciences (NBIX)Buy $105.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/4/2019OppenheimerInitiatesCatalyst Biosciences (CBIO)Outperform$24.00 -> $24.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/3/2019OppenheimerUpgradesGilead Sciences (GILD)Market Perform -> Outperform $85.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/2/2019OppenheimerInitiatesMarina Biotech (MRNA)Outperform $27.00HighView Rating Details  Share on Twitter  Share on StockTwits
1/2/2019OppenheimerSet Price TargetDiamondback Energy (FANG)Buy $158.00MediumView Rating Details  Share on Twitter  Share on StockTwits
1/2/2019OppenheimerSet Price TargetAcorda Therapeutics (ACOR)Hold $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/31/2018OppenheimerSet Price TargetPortola Pharmaceuticals (PTLA)Buy $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/26/2018OppenheimerSet Price TargetMueller Water Products (MWA)Buy $13.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/28/2018OppenheimerSet Price TargetCTI BioPharma (CTIC)Buy $4.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/28/2018OppenheimerLowers TargetBiohaven Pharmaceutical (BHVN)Outperform$63.00 -> $54.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/24/2018OppenheimerSet Price TargetDiamondback Energy (FANG)Buy FANG $158.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/24/2018OppenheimerSet Price TargetAcorda Therapeutics (ACOR)Hold ACOR $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/23/2018OppenheimerSet Price TargetJazz Pharmaceuticals (JAZZ)Buy $180.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/20/2018OppenheimerReiteratesCarMax (KMX)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
12/20/2018OppenheimerReiteratesO'Reilly Automotive (ORLY)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
12/20/2018OppenheimerSet Price TargetADMA Biologics (ADMA)Buy ADMA $13.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/21/2018OppenheimerInitiatesLoxo Oncology (LOXO)Buy $185.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/20/2018OppenheimerLowers TargetColfax (CFX)Outperform$37.00 -> $30.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/19/2018OppenheimerLowers TargetFedEx (FDX)Outperform$288.00 -> $234.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/19/2018OppenheimerInitiatesInVitae (NVTA)Outperform $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/19/2018OppenheimerInitiatesGenomic Health (GHDX)Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
12/18/2018OppenheimerLowers TargetBiogen (BIIB)Outperform$380.00 -> $372.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018OppenheimerDowngradesCarlisle Companies (CSL)Outperform -> Market PerformMediumView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018OppenheimerSet Price TargetEvofem Biosciences (EVFM)Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/17/2018OppenheimerInitiatesTwin Disc (TWIN)Buy $20.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/16/2018OppenheimerUpgradesCarlisle Companies (CSL)Market Perform -> Outperform $125.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/14/2018OppenheimerSet Price TargetConforMIS (CFMS)Buy $3.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/13/2018OppenheimerSet Price TargetMesoblast (MESO)Buy $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/13/2018OppenheimerSet Price TargetFrontdoor (FTDR)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/14/2018OppenheimerSet Price TargetViper Energy Partners (VNOM)Buy $49.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/14/2018OppenheimerLowers TargetCostco Wholesale (COST)$262.00 -> $240.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/14/2018OppenheimerRaises TargetTrade Desk (TTD)Outperform$130.00 -> $160.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/13/2018OppenheimerInitiatesBioMarin Pharmaceutical (BMRN)Hold $92.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/13/2018OppenheimerLowers TargetNeurocrine Biosciences (NBIX)Outperform$140.00 -> $105.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/12/2018OppenheimerSet Price TargetAzurRx BioPharma (AZRX)Buy $6.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/12/2018OppenheimerSet Price TargetBiogen (BIIB)Buy $380.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/12/2018OppenheimerSet Price TargetPeak Resorts (SKIS)Buy $7.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/11/2018OppenheimerSet Price TargetNeurocrine Biosciences (NBIX)Buy $140.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/11/2018OppenheimerReiteratesAcelRx Pharmaceuticals (ACRX)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
12/11/2018OppenheimerSet Price TargetServicemaster Global (SERV)Buy $47.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/12/2018OppenheimerSet Price TargetBIOLINERX LTD/S (BLRX)Buy $3.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/11/2018OppenheimerInitiatesJazz Pharmaceuticals (JAZZ)Buy$180.00 -> $180.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/11/2018OppenheimerInitiatesGW Pharmaceuticals PLC- (GWPH)Hold$142.00 -> $142.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/11/2018OppenheimerDowngradesVanda Pharmaceuticals (VNDA)Outperform -> Hold $29.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/11/2018OppenheimerLowers TargetTivity Health (TVTY)Outperform$44.00 -> $34.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/11/2018OppenheimerLowers TargetUlta Beauty (ULTA)Outperform -> Outperform$375.00 -> $340.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/11/2018OppenheimerInitiatesBioTime (BTX)Outperform $3.50N/AView Rating Details  Share on Twitter  Share on StockTwits
12/10/2018OppenheimerInitiatesMolecular Templates (MTEM)Outperform$15.00 -> $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/10/2018OppenheimerInitiatesNovavax (NVAX)Outperform$4.00 -> $4.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/10/2018OppenheimerSet Price TargetIngevity (NGVT)Buy $110.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/10/2018OppenheimerSet Price TargetBiohaven Pharmaceutical (BHVN)Buy $63.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/9/2018OppenheimerSet Price TargetCymaBay Therapeutics (CBAY)Buy $18.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/9/2018OppenheimerSet Price TargetPortola Pharmaceuticals (PTLA)Buy $30.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/10/2018OppenheimerSet Price TargetCeragon Networks (CRNT)Buy $5.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/7/2018OppenheimerRaises TargetOmnicell (OMCL)Outperform $86.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/7/2018OppenheimerSet Price TargetCooper Companies (COO)Hold $282.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/7/2018OppenheimerSet Price TargetWyndham Hotels & Resorts (WH)Buy $69.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/6/2018OppenheimerInitiatesPar Pacific (PARR)Outperform$22.00 -> $22.00N/AView Rating Details  Share on Twitter  Share on StockTwits
12/6/2018OppenheimerSet Price TargetDexCom (DXCM)Buy $150.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/5/2018OppenheimerSet Price TargetResideo Technologies (REZI)Buy $35.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/6/2018OppenheimerSet Price TargetConatus Pharmaceuticals (CNAT)Buy$14.00 -> $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/6/2018OppenheimerSet Price TargetZimmer Biomet (ZBH)Buy $135.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/5/2018OppenheimerSet Price TargetLendingtree (TREE)Buy $300.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/5/2018OppenheimerSet Price TargetHewlett Packard Enterprise (HPE)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/4/2018OppenheimerReiteratesbluebird bio (BLUE)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
12/4/2018OppenheimerReiteratesDonaldson (DCI)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018OppenheimerReiteratesVanda Pharmaceuticals (VNDA)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
12/4/2018OppenheimerSet Price TargetMadrigal Pharmaceuticals (MDGL)Buy $200.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018OppenheimerInitiatesAerie Pharmaceuticals (AERI)Buy $64.00MediumView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018OppenheimerSet Price TargetBiohaven Pharmaceutical (BHVN)Buy $63.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018OppenheimerSet Price TargetGlobal Blood Therapeutics (GBT)Buy $82.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018OppenheimerReiteratesTractor Supply (TSCO)Outperform -> Market Perform $100.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/3/2018OppenheimerSet Price TargetAlpine Immune Sciences (ALPN)Buy $13.00LowView Rating Details  Share on Twitter  Share on StockTwits
12/2/2018OppenheimerSet Price TargetIntec Pharma (NTEC)Buy $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
12/2/2018OppenheimerSet Price TargetRegeneron Pharmaceuticals (REGN)Buy $440.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/30/2018OppenheimerDowngradesDenbury Resources (DNR)Outperform -> Hold $9.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/29/2018OppenheimerSet Price TargetCatalyst Pharmaceuticals (CPRX)Buy $6.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/29/2018OppenheimerLowers TargetEllie Mae (ELLI)Outperform$92.00 -> $80.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/29/2018OppenheimerSet Price TargetArQule (ARQL)Buy $7.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/28/2018OppenheimerRaises TargetUnitedHealth Group (UNH)Outperform$295.00 -> $300.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/27/2018OppenheimerReiteratesAlliance Data Systems (ADS)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
11/27/2018OppenheimerReiteratesbluebird bio (BLUE)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
11/27/2018OppenheimerSet Price TargetCorporacion America Airports (CAAP)Buy $12.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/27/2018OppenheimerSet Price TargetVertex Pharmaceuticals (VRTX)Buy $200.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/28/2018OppenheimerInitiatesSolar Capital (SLRC)Buy $23.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/28/2018OppenheimerSet Price TargetActinium Pharmaceuticals (ATNM)Buy $5.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/28/2018OppenheimerSet Price TargetKura Oncology (KURA)Buy $32.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/27/2018OppenheimerReiteratesFerroglobe (GSM)Outperform -> Market Perform $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/26/2018OppenheimerSet Price TargetAlexion Pharmaceuticals (ALXN)Buy $165.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/26/2018OppenheimerSet Price TargetMotus GI (MOTS)Buy $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/26/2018OppenheimerDowngradesFerroglobe (GSM)Outperform -> Market Perform $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/27/2018OppenheimerSet Price TargetITT (ITT)Buy $68.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/27/2018OppenheimerSet Price TargetEnanta Pharmaceuticals (ENTA)Hold $100.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/25/2018OppenheimerSet Price TargetCellectis (CLLS)Buy $44.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/21/2018OppenheimerReiteratesBoston Scientific (BSX)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
11/21/2018OppenheimerSet Price TargetValeritas (VLRX)Buy $2.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/21/2018OppenheimerReiteratesEcolab (ECL)Outperform -> Market PerformLowView Rating Details  Share on Twitter  Share on StockTwits
11/21/2018OppenheimerLowers TargetAutodesk (ADSK)Outperform -> Outperform$175.00 -> $160.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/20/2018OppenheimerSet Price TargetUnited Therapeutics (UTHR)Buy $160.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/21/2018OppenheimerReiteratesDexCom (DXCM)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
11/21/2018OppenheimerInitiatesGamida Cell (GMDA)Outperform $15.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/20/2018OppenheimerSet Price TargetSAGE Therapeutics (SAGE)Buy $170.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/19/2018OppenheimerSet Price TargetPure Storage (PSTG)Buy $26.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/20/2018OppenheimerReiteratesMedtronic (MDT)Buy $104.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/19/2018OppenheimerReiteratesColfax (CFX)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
11/19/2018OppenheimerSet Price TargetAzurRx BioPharma (AZRX)Buy $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/19/2018OppenheimerLowers TargetMadrigal Pharmaceuticals (MDGL)Outperform$300.00 -> $200.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/19/2018OppenheimerSet Price TargetMicrosoft (MSFT)Buy $127.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/19/2018OppenheimerDowngradesSpectrum Brands (SPB)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
11/18/2018OppenheimerReiteratesCarlisle Companies (CSL)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
11/19/2018OppenheimerUpgradesIntercept Pharmaceuticals (ICPT)Market Perform -> Outperform $140.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/16/2018OppenheimerLowers TargetTapestry (TPR)Outperform$65.00 -> $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/16/2018OppenheimerLowers TargetNVIDIA (NVDA)Outperform$310.00 -> $250.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/16/2018OppenheimerReiteratesAgios Pharmaceuticals (AGIO)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
11/16/2018OppenheimerReiteratesIdeal Power (IPWR)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
11/16/2018OppenheimerDowngradesMichael Kors (KORS)Outperform -> Market Perform $90.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/15/2018OppenheimerSet Price TargetCelsion (CLSN)Buy $9.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/15/2018OppenheimerSet Price TargetIntec Pharma (NTEC)Buy $15.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/15/2018OppenheimerSet Price TargetSix Flags Entertainment (SIX)Buy $80.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/16/2018OppenheimerSet Price TargetEvofem Biosciences (EVFM)Buy $9.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/16/2018OppenheimerSet Price TargetMustang Bio (MBIO)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/15/2018OppenheimerSet Price TargetKemPharm (KMPH)Buy $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/15/2018OppenheimerSet Price TargetSLS International (SLS)Buy $13.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/15/2018OppenheimerReiteratesFerroglobe (GSM)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
11/15/2018OppenheimerSet Price TargetEpizyme (EPZM)Buy $27.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/15/2018OppenheimerSet Price TargetExelixis (EXEL)Buy $40.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/15/2018OppenheimerSet Price TargetAvenue Therapeutics (ATXI)Buy $10.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/14/2018OppenheimerSet Price TargetMediwound (MDWD)Buy $14.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/14/2018OppenheimerReiteratesNetApp (NTAP)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
11/14/2018OppenheimerSet Price TargetIngevity (NGVT)Buy $110.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/14/2018OppenheimerReiteratesGilead Sciences (GILD)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
11/15/2018OppenheimerReiteratesSabre (SABR)BuyLowView Rating Details  Share on Twitter  Share on StockTwits
11/15/2018OppenheimerDowngradesEAGLE POINT CR/COM (ECC)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
11/14/2018OppenheimerSet Price TargetCatabasis Pharmaceuticals (CATB)Buy $70.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/14/2018OppenheimerLowers TargetWix.Com (WIX)Outperform$125.00 -> $113.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/14/2018OppenheimerLowers TargetJohnson Controls International (JCI)Outperform$44.00 -> $39.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/13/2018OppenheimerSet Price TargetCymaBay Therapeutics (CBAY)Buy $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/13/2018OppenheimerSet Price TargetResideo Technologies (REZI)Buy $35.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/14/2018OppenheimerSet Price TargetAlexion Pharmaceuticals (ALXN)Buy $165.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/13/2018OppenheimerSet Price TargetVaccinex (VCNX)Buy $22.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/13/2018OppenheimerSet Price TargetMadrigal Pharmaceuticals (MDGL)Buy $300.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/13/2018OppenheimerSet Price TargetSyros Pharmaceuticals (SYRS)Buy $26.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018OppenheimerSet Price TargetADMA Biologics (ADMA)Buy $13.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/13/2018OppenheimerReiteratesCtrip.Com International (CTRP)BuyMediumView Rating Details  Share on Twitter  Share on StockTwits
11/13/2018OppenheimerSet Price TargetUrogen Pharma (URGN)Buy $75.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018OppenheimerInitiatesAerie Pharmaceuticals (AERI)Buy $64.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018OppenheimerInitiatesBiohaven Pharmaceutical (BHVN)Buy $63.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018OppenheimerSet Price TargetMesoblast (MESO)Buy $15.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/11/2018OppenheimerSet Price TargetJuniper Networks (JNPR)Buy $33.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/11/2018OppenheimerReiteratesFlowserve (FLS)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
11/11/2018OppenheimerSet Price TargetSLM (SLM)Buy $13.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/11/2018OppenheimerReiteratesAxovant Sciences (AXON)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
11/11/2018OppenheimerInitiatesSpero Therapeutics (SPRO)Buy $30.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018OppenheimerSet Price TargetSynlogic (SYBX)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018OppenheimerSet Price TargetAlpine Immune Sciences (ALPN)Buy $13.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018OppenheimerSet Price TargetAduro BioTech (ADRO)Buy $10.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/12/2018OppenheimerSet Price TargetSorrento Therapeutics (SRNE)Buy $10.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/11/2018OppenheimerSet Price TargetMirati Therapeutics (MRTX)Buy $57.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/11/2018OppenheimerSet Price TargetTESARO (TSRO)Buy $83.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/11/2018OppenheimerReiteratesProthena (PRTA)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerLowers TargetCenturylink (CTL)Outperform$24.00 -> $22.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerLowers TargetZayo Group (ZAYO)Outperform $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerLowers TargetGTT Communications (GTT)Outperform $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerSet Price TargetStryker (SYK)Hold $170.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerSet Price TargetGlobus Medical (GMED)Hold $61.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerLowers TargetActivision Blizzard (ATVI)Outperform$87.00 -> $68.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerLowers TargetSkyworks Solutions (SWKS)Outperform$120.00 -> $110.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018OppenheimerSet Price TargetCatalyst Pharmaceuticals (CPRX)Buy $6.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerSet Price TargetTandem Diabetes Care (TNDM)Buy $57.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerSet Price TargetSeres Therapeutics (MCRB)Buy $16.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerSet Price TargetThe Medicines (MDCO)Buy $50.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerSet Price TargetVolitionRX (VNRX)Buy $5.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerReiteratesPra Group (PRAA)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
11/9/2018OppenheimerSet Price TargetBIOLINERX LTD/S (BLRX)Buy $3.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018OppenheimerRaises TargetHubSpot (HUBS)Outperform$150.00 -> $160.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018OppenheimerRaises TargetCyberark Software (CYBR)Outperform$75.00 -> $89.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018OppenheimerRaises TargetChurch & Dwight (CHD)Outperform$66.00 -> $73.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018OppenheimerReiteratesDenbury Resources (DNR)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerSet Price TargetTherapeuticsMD (TXMD)Buy $14.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerSet Price TargetEvofem Biosciences (EVFM)Buy $9.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018OppenheimerSet Price TargetPortola Pharmaceuticals (PTLA)Buy$60.00 -> $30.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018OppenheimerSet Price TargetWright Medical Group (WMGI)Hold $30.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018OppenheimerSet Price TargetRecro Pharma (REPH)Buy $18.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018OppenheimerSet Price TargetVanda Pharmaceuticals (VNDA)Buy $29.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/8/2018OppenheimerReiteratesEncore Capital Group (ECPG)HoldN/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerReiteratesVector Group (VGR)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerLowers TargetTurtle Beach (HEAR)Outperform$35.00 -> $24.00N/AView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerRaises TargetAddus Homecare (ADUS)Outperform$72.00 -> $80.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerSet Price TargetCymaBay Therapeutics (CBAY)Buy $18.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerSet Price TargetCompugen (CGEN)Buy $9.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerSet Price TargetRadware (RDWR)Buy $30.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerSet Price TargetCDK Global (CDK)Buy $67.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerDowngradesEndurance International Group (EIGI)Outperform -> Market PerformHighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerReiteratesQEP Resources (QEP)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerSet Price TargetGlobal Blood Therapeutics (GBT)Buy$74.00 -> $82.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerSet Price TargetDexCom (DXCM)Buy $150.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/7/2018OppenheimerReiteratesTeva Pharmaceutical Industries (TEVA)HoldMediumView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018OppenheimerReiteratesDiamondback Energy (FANG)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018OppenheimerReiteratesAllot Communications (ALLT)HoldLowView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018OppenheimerSet Price TargetForterra (FRTA)Buy $13.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/6/2018OppenheimerSet Price TargetServicemaster Global (SERV)Buy $47.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018OppenheimerReiteratesMueller Water Products (MWA)BuyHighView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018OppenheimerSet Price TargetNeurocrine Biosciences (NBIX)Buy $140.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018OppenheimerSet Price TargetFrontdoor (FTDR)Buy $40.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018OppenheimerSet Price TargetAmerican Express (AXP)Buy $114.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/5/2018OppenheimerSet Price TargetCeragon Networks (CRNT)Buy $5.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/4/2018OppenheimerReiteratesWatts Water Technologies (WTS)HoldHighView Rating Details  Share on Twitter  Share on StockTwits
11/4/2018OppenheimerSet Price TargetSAGE Therapeutics (SAGE)Buy $170.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/4/2018OppenheimerSet Price TargetVistagen Therapeutics (VTGN)Buy $6.00MediumView Rating Details  Share on Twitter  Share on StockTwits
11/4/2018OppenheimerSet Price TargetStoneCastle Financial (BANX)Buy $24.00LowView Rating Details  Share on Twitter  Share on StockTwits
11/4/2018OppenheimerSet Price TargetGulfport Energy (GPOR)Buy $18.00HighView Rating Details  Share on Twitter  Share on StockTwits
11/2/2018OppenheimerRaises TargetStarbucks (SBUX)Outperform$61.00 -> $70.00MediumView Rating Details  Share on Twitter  Share on StockTwits

This page was last refreshed on Tuesday at 02:58 AM ET.

MarketBeat Community Rating for Oppenheimer

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  169 (Vote Outperform)
Underperform Votes:  193 (Vote Underperform)
Total Votes:  362
MarketBeat's community ratings are surveys of what our community members think about Oppenheimer and other research firms. Vote "Outperform" if you believe Oppenheimer's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Oppenheimer's recmomendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel